Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 2 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.


Player Avatar carlsbadkevin (< 20) Submitted: 7/16/2013 3:38:40 PM : Outperform Start Price: $44.03 LGND Score: -4.52

royalties plus a great pipeline

Featured Broker Partners